IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $77,000 | +24.2% | 10,713 | +1.6% | 0.00% | – |
Q4 2020 | $62,000 | +100.0% | 10,548 | -8.2% | 0.00% | – |
Q3 2020 | $31,000 | -93.6% | 11,493 | -89.3% | 0.00% | -100.0% |
Q2 2020 | $485,000 | +2594.4% | 107,646 | +298.3% | 0.00% | – |
Q3 2019 | $18,000 | -21.7% | 27,027 | +11.5% | 0.00% | – |
Q2 2019 | $23,000 | -37.8% | 24,238 | +135.6% | 0.00% | – |
Q4 2018 | $37,000 | -64.4% | 10,288 | -5.2% | 0.00% | -100.0% |
Q2 2018 | $104,000 | -12.6% | 10,857 | -4.2% | 0.00% | 0.0% |
Q1 2018 | $119,000 | +60.8% | 11,334 | -6.3% | 0.00% | 0.0% |
Q4 2017 | $74,000 | -28.2% | 12,097 | -8.5% | 0.00% | 0.0% |
Q3 2017 | $103,000 | -19.5% | 13,220 | -23.1% | 0.00% | 0.0% |
Q2 2017 | $128,000 | +93.9% | 17,184 | -0.1% | 0.00% | 0.0% |
Q1 2017 | $66,000 | +288.2% | 17,202 | +23.6% | 0.00% | – |
Q4 2016 | $17,000 | -62.2% | 13,913 | -28.5% | 0.00% | -100.0% |
Q3 2016 | $45,000 | -70.0% | 19,461 | +12.6% | 0.00% | – |
Q1 2016 | $150,000 | -38.0% | 17,284 | -4.7% | 0.00% | -100.0% |
Q4 2015 | $242,000 | – | 18,144 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |